butabarbital will lower the extent or impact of zonisamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.

Phenobarbital seems to interfere Along with the absorption of orally administered griseofulvin, Hence decreasing its blood level.

Generally speak to your Health care supplier to ensure the knowledge exhibited on this webpage applies to your own conditions.

Unusual situations of angioedema involving the tongue, glottis or larynx are claimed in people just after having the primary or subsequent doses of sedative-hypnotics. Some patients have had extra signs or symptoms for instance dyspnea, throat closing, or nausea and vomiting that advise anaphylaxis.

butabarbital will lessen the level or effect of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.

Scenario studies of withdrawal seizures in newborns whose mothers experienced taken butalbital-made up of medications in the course of pregnancy.

butabarbital will lower the extent or outcome of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Not known.

butabarbital read more will lower the extent or impact of midostaurin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Potent CYP3A4 inducers may well decrease midostaurin concentrations leading to decreased efficacy.

butabarbital will reduce the level or impact of vincristine liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.

The usage of barbiturates carries with it an connected risk of psychological and/or physical dependence. The affected individual must be warned from expanding the dose with the drug without consulting a medical professional.

Hypersensitivity to barbiturates or any ingredient of your formulation; ; record of manifest or latent porphyria

Clients with acute or Continual pain (apart from pain after surgical procedure or chemotherapy)—Use with caution. May possibly bring about an opposite influence to one and that is Commonly anticipated and mask indications of other not known conditions.

butabarbital will decrease the level or outcome of tamoxifen by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

butabarbital will minimize the extent or effect of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.